Home Cart Sign in  
Chemical Structure| 1818389-84-2 Chemical Structure| 1818389-84-2

Structure of SPHINX31
CAS No.: 1818389-84-2

Chemical Structure| 1818389-84-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SPHINX31 is a potent and selective inhibitor of serine/arginine-rich protein kinase 1 (SRPK1), with an IC50 of 5.9 nM. SPHINX31 inhibits phosphorylation of serine/arginine-rich splicing factor 1 (SRSF1). SPHINX31 is a potential topical therapeutic for neovascular eye disease[1].

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SPHINX31

CAS No. :1818389-84-2
Formula : C27H24F3N5O2
M.W : 507.51
SMILES Code : O=C(C1=CC=C(C2=CC=NC=C2)O1)NC3=CC(C(F)(F)F)=CC=C3N4CCN(CC5=NC=CC=C5)CC4
MDL No. :MFCD31810499
InChI Key :VURLRACCOCGFDB-UHFFFAOYSA-N
Pubchem ID :91972002

Safety of SPHINX31

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SPHINX31

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Peripheral blood lymphocytes (PBLs) 12.5 µM 24 hours Inhibition of SRPK1 suppressed cell proliferation and induced apoptosis BMC Cancer. 2022 Oct 27;22(1):1100.
YT cells 12.5 µM 24 hours Inhibition of SRPK1 suppressed cell proliferation and induced apoptosis BMC Cancer. 2022 Oct 27;22(1):1100.
Jurkat T cells 1 µM 24 hours SPHINX31 completely ameliorated the suppression of IL-2 production by MM418 melanoma cells in Jurkat cells Cancer Immunol Immunother. 2023 Dec;72(12):4001-4014.
A549 5 µM 24 hours Evaluated the effect of SPHINX31 in combination with indisulam on cell proliferation, showing increased splicing errors and inhibited cell proliferation Life Sci Alliance. 2022 May 9;5(9):e202101348.
Human umbilical vein endothelial cells (HUVECs) 1, 2.5, 5 µM 24 hours To evaluate the effect of SPHINX31 on HUVECs cell viability. Results showed that SPHINX31 significantly inhibited HUVECs cell viability in a dose-dependent manner. Front Pharmacol. 2022 Jun 30;13:920601.
H2122 2.5 µM Evaluated the effect of SPHINX31 in combination with indisulam on cell proliferation Life Sci Alliance. 2022 May 9;5(9):e202101348.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.85mL

1.97mL

0.99mL

19.70mL

3.94mL

1.97mL

References

 

Historical Records

Categories